NMR-Tomographie bei Blasen- und Prostataerkrankungen -

Beer, M.; Rath, M; Staebler, G.; Baierl, P.; Schmiedt, E

doi:10.1055/s-2008-1062583

Cited by 4 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Theoretically, such tumours of the bladder can be irradiated effectively by transurethral laser treatment. However, pre-operative staging, even with CT and N M R scans (Beer et al, 1985;Amendola et al, 1986), does not give a sufficiently accurate assessment of muscle invasiveness and can lead to significant errors in clinically understaging bladder cancer (Smith et al, 1982). As a result, a "treatment failure" in understaged patients might be deduced.…”

Section: Discussionmentioning

confidence: 99%

Adjuvant Laser Treatment of Bladder Cancer: 8 Years' Experience with the Nd‐YAG Laser 1064 nm

Beer¹,

Jocham²,

Beer³

et al. 1989

British Journal of Urology

Self Cite

View full text Add to dashboard Cite

Following the development of suitable equipment for the endoscopic application of an Nd-YAG laser in this department, the laser has been used routinely in the management of bladder cancer since 1978. To evaluate side effects and efficiency, 252 consecutive laser treatments were evaluated with a minimum follow-up of 12 months. Side effects were few (0.3% perforation) and patients tolerated the treatment very well. The general recurrence rate of T1 tumours varied from 33% for primary carcinomas to 54% for recurrent tumours, but the incidence of local recurrence was only 7%. The long-term results of laser treatment showed a decrease in the local recurrence rate when compared with the results of conservative electocautery resection, but there was no significant influence on the total recurrence rate.

show abstract

Section: Discussionmentioning

confidence: 99%